Long-term beneficial effects of a nifedipine-supplemented immunosuppressive regimen in kidney transplantation.
Shin
G T
GT
Rogosin Institute, New York, NY, USA.
Cheigh
J S
JS
Riggio
R R
RR
Suthanthiran
M
M
Stubenbord
W T
WT
Serur
D
D
Wang
J C
JC
Rubin
A
A
Stenzel
K H
KH
D000328:Adult; D001794:Blood Pressure; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008297:Male; D009543:Nifedipine / Q000627:therapeutic use*; D015996:Survival Rate
D002121:Calcium Channel Blockers; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D009543:Nifedipine